Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,768 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00542542 | Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery | completed | Phase 3 | 89 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 13, 2015 | clinicaltrials |
| NCT00958256 | Study of Bortezomib in Combination With Cyclophosphamide and Rituximab | completed | Phase 2 | 22 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 13, 2015 | clinicaltrials |
| NCT02095847 |
| High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection |
| withdrawn |
| Phase 2 |
| 0 |
| M.D. Anderson Cancer CenterOTHER |
| 0 |
| Apr 8, 2015 |
| clinicaltrials |
| NCT00028418 | Clofarabine in Chronic Lymphocytic Leukemia | completed | Phase 1 | 100 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 25, 2015 | clinicaltrials |
| NCT00410189 | BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC | completed | Phase 2 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 23, 2015 | clinicaltrials |
| NCT00054691 | ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin | completed | Phase 2 | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 13, 2015 | clinicaltrials |
| NCT00656617 | Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) | completed | Phase 2 | 106 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT00825240 | Formative Study of Tailored Survivor Health Promotion | completed | — | 15 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT01048983 | Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC) | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Mar 5, 2015 | clinicaltrials |
| NCT00432445 | Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma | terminated | Phase 2 | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 27, 2015 | clinicaltrials |
| NCT00543842 | Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer | completed | Phase 1 | 19 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 26, 2015 | clinicaltrials |
| NCT00967044 | Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma | completed | Phase 1 / Phase 2 | 31 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 26, 2015 | clinicaltrials |
| NCT01219673 | Symptom Burden in Head and Neck Cancer | terminated | Phase 1 / Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 10, 2015 | clinicaltrials |
| NCT00525915 | Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma | completed | Phase 2 | 126 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 9, 2015 | clinicaltrials |
| NCT01321008 | Stage I/II Nasal NK Cell Lymphoma | terminated | Phase 1 / Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 5, 2015 | clinicaltrials |
| NCT00903006 | Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer | terminated | Phase 1 / Phase 2 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 2, 2015 | clinicaltrials |
| NCT00631527 | Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer | completed | Phase 1 | 19 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 29, 2015 | clinicaltrials |
| NCT00429338 | 3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate | terminated | N/A | 8 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT00487331 | Acupuncture for Treatment of Uncontrolled Pain: A Feasibility Study | completed | N/A | 52 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT00535067 | Neuropathic Pain in Survivors of Breast Cancer | completed | — | 239 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT00614276 | Female Sexual Dysfunction Intervention | completed | — | 91 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT00788476 | Childhood Cancer Survivor Survey | completed | — | 167 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT00824902 | Evaluation Ultrasound Elasticity/Tissue Strain-Hardening Imaging for Prostate Cancer Patients Undergoing Radical Prostatectomy | terminated | N/A | 13 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT00876499 | Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients | completed | — | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT00489593 | Olanzapine in Patients With Advanced Cancer and Weight Loss | completed | Phase 1 | 57 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 8, 2015 | clinicaltrials |
| NCT00530907 | Valproic Acid and Bevacizumab in Patients With Advanced Cancer | completed | Phase 1 | 71 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 8, 2015 | clinicaltrials |
| NCT01095913 | Fluorescent Dyes for Lymph Node Mapping | completed | Phase 1 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 8, 2015 | clinicaltrials |
| NCT01193036 | Symptom Burden in Patients With Cancer- and Treatment-Related Skin Problems | terminated | — | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 8, 2015 | clinicaltrials |
| NCT01201694 | Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L) | completed | Phase 1 | 28 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 8, 2015 | clinicaltrials |
| NCT00507260 | Nutritional Assessment Intervention to Improve Cancer-Related Fatigue | completed | N/A | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 24, 2014 | clinicaltrials |
| NCT00354523 | Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma | terminated | Phase 1 / Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 17, 2014 | clinicaltrials |
| NCT00756470 | Phase II Neoadjuvant in Inflammatory Breast Cancer | terminated | Phase 2 | 15 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 17, 2014 | clinicaltrials |
| NCT00388154 | Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer | completed | Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 13, 2014 | clinicaltrials |
| NCT01320787 | 18-F-Fluoroacetate as PET Imaging Agent | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 23, 2014 | clinicaltrials |
| NCT00505895 | FM 140 vs FM100 Study in Patients With Multiple Myeloma | completed | Phase 2 | 52 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 17, 2014 | clinicaltrials |
| NCT00349596 | A Study of Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL) | completed | Phase 1 | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 15, 2014 | clinicaltrials |
| NCT00506597 | Erwinase Study in Patients With Acute Lymphoblastic Leukemia | completed | N/A | 33 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 11, 2014 | clinicaltrials |
| NCT01538472 | Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma | completed | Phase 1 / Phase 2 | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 11, 2014 | clinicaltrials |
| NCT00673179 | Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy | terminated | N/A | 7 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 10, 2014 | clinicaltrials |
| NCT00787527 | SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma | completed | Phase 1 / Phase 2 | 14 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 9, 2014 | clinicaltrials |
| NCT00867477 | PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide | completed | Phase 2 | 163 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 28, 2014 | clinicaltrials |
| NCT01515566 | Breakthrough Dyspnea Fentanyl Study in Cancer Patients | completed | Phase 1 / Phase 2 | 26 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 22, 2014 | clinicaltrials |
| NCT01008930 | Feasibility Study for Imaging of Peripheral Tumors With a High-Resolution PET Imaging System | completed | N/A | 19 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 20, 2014 | clinicaltrials |
| NCT00113334 | Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer | completed | Phase 1 / Phase 2 | 6 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2014 | clinicaltrials |
| NCT00776958 | Lynne Cohen Consortium Project: Multi-Center Database/Registry | completed | — | 176 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2014 | clinicaltrials |
| NCT01627080 | Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 28, 2014 | clinicaltrials |
| NCT01864070 | Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 22, 2014 | clinicaltrials |
| NCT02193672 | A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 18, 2014 | clinicaltrials |
| NCT00909207 | Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing | completed | — | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 14, 2014 | clinicaltrials |
| NCT02114502 | Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 11, 2014 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials